Your browser doesn't support javascript.
loading
Metabolomics: The Stethoscope for the Twenty-First Century.
Ashrafian, Hutan; Sounderajah, Viknesh; Glen, Robert; Ebbels, Timothy; Blaise, Benjamin J; Kalra, Dipak; Kultima, Kim; Spjuth, Ola; Tenori, Leonardo; Salek, Reza M; Kale, Namrata; Haug, Kenneth; Schober, Daniel; Rocca-Serra, Philippe; O'Donovan, Claire; Steinbeck, Christoph; Cano, Isaac; de Atauri, Pedro; Cascante, Marta.
Afiliação
  • Ashrafian H; Institute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Sounderajah V; Institute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Glen R; Institute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Ebbels T; Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, United Kingdom.
  • Blaise BJ; Institute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Kalra D; Institute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Kultima K; Department of Medical Informatics and Statistics, University of Ghent, Ghent, Belgium.
  • Spjuth O; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Tenori L; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Salek RM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Kale N; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
  • Haug K; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
  • Schober D; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
  • Rocca-Serra P; Department of Stress and Developmental Biology, Leibniz Institute of Plant Biochemistry, Halle (Saale), Germany.
  • O'Donovan C; Department of Engineering Science, Oxford e-Research Centre, University of Oxford, Oxford, United Kingdom.
  • Steinbeck C; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
  • Cano I; Institute for Inorganic and Analytical Chemistry, Friedrich-Schiller-University, Jena, Germany.
  • de Atauri P; Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
  • Cascante M; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona and CIBERHD (CIBER de Enfermedades hepáticas y digestivas), Barcelona, Spain.
Med Princ Pract ; 30(4): 301-310, 2021.
Article em En | MEDLINE | ID: mdl-33271569
Metabolomics encompasses the systematic identification and quantification of all metabolic products in the human body. This field could provide clinicians with novel sets of diagnostic biomarkers for disease states in addition to quantifying treatment response to medications at an individualized level. This literature review aims to highlight the technology underpinning metabolic profiling, identify potential applications of metabolomics in clinical practice, and discuss the translational challenges that the field faces. We searched PubMed, MEDLINE, and EMBASE for primary and secondary research articles regarding clinical applications of metabolomics. Metabolic profiling can be performed using mass spectrometry and nuclear magnetic resonance-based techniques using a variety of biological samples. This is carried out in vivo or in vitro following careful sample collection, preparation, and analysis. The potential clinical applications constitute disruptive innovations in their respective specialities, particularly oncology and metabolic medicine. Outstanding issues currently preventing widespread clinical use are scalability of data interpretation, standardization of sample handling practice, and e-infrastructure. Routine utilization of metabolomics at a patient and population level will constitute an integral part of future healthcare provision.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estetoscópios / Metabolômica / Medicina de Precisão Limite: Humans Idioma: En Revista: Med Princ Pract Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estetoscópios / Metabolômica / Medicina de Precisão Limite: Humans Idioma: En Revista: Med Princ Pract Ano de publicação: 2021 Tipo de documento: Article